The Magazine for Sleep Professionals
Friday, July 24, 2026
In support of World Asthma Day, May 2, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, urges more availability to effective medications and health care for persons with asthma. It is estimated that between 300 and 400 million people worldwide suffer […]
Multifaceted approach to treatment offers significant financial benefits while improving quality of patient care Royal Philips announced results(1) from a recent study showing significant decreases in both hospital and payer costs and hospitalization rates for severe chronic obstructive pulmonary disease (COPD)(2) patients. The study entitled, “Cost Savings from Reduced Hospitalizations […]
Sleek product design and engaging smartphone app revolutionizes CPAP experience for the world’s 100 million sleep apnea sufferers ResMed today unveiled its AirMini™, the world’s smallest CPAP machine – a game-changer for people with sleep apnea. Achieving new heights in patient-centered innovation, AirMini packs ResMed’s clinically proven CPAP technology along […]
Advanced CPAP offers same clinically-proven therapy as Philips’ award-winning DreamStation at half the size for reliable, uninterrupted therapy while on-the-go Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of DreamStation Go, its newest and smallest positive airway pressure (PAP) device designed to simplify travel […]
Scientists have known that a lack of sleep can interfere with the ability to learn and make memories. Now, a group of University of Michigan researchers have found how sleep deprivation affects memory-making in the brain. Previously, researchers knew that depriving mice of sleep after the mice performed a task resulted […]
ResMed Inc. today announced that people with obstructive sleep apnea who develop central sleep apnea (CSA) are more compliant on therapy after they switch from continuous positive airway pressure (CPAP) therapy to adaptive servo-ventilation (ASV) therapy, according to the largest-ever analysis of patients with treatment-emergent CSA. The study analyzed anonymous, […]
The American Thoracic Society today announced a new $100,000 two-year research fellowship in the area of noninvasive ventilation (NIV) in chronic obstructive pulmonary disease (COPD). The “ATS Foundation/ResMed Research Fellowship in Noninvasive Ventilation in COPD” award is funded by ResMed (NYSE:RMD), a global leader in NIV devices for treating COPD in […]
Dräger today announced that its portfolio of medical ventilators has received the Frost & Sullivan 2017 Medical Ventilation Product Leadership Award. Considered best-in-class by various hospitals and health systems, Dräger’s ventilators were recognized for their reliability and quality, stellar support services and robust, flexible design, fitting the needs of a […]
UTIBRON NEOHALER is a new combination therapy for people with chronic obstructive pulmonary disease (COPD) that addresses unmet patient needs Sunovion Pharmaceuticals Inc today announced that Utibron™Neohaler® (indacaterol/glycopyrrolate) inhalation powder is now available at pharmacies in the United States for the long-term maintenance treatment of airflow obstruction in people with chronic […]
Philips today announced that it has signed an agreement to acquire Australian Pharmacy Sleep Services (APSS), a pioneer in pharmacy sleep testing. Headquartered in Sydney, APSS will complement Philips’ sleep and respiratory care offering, and will help to accelerate the business’ home sleep testing offering through the pharmacy channel in […]
